Acarix AB

Chart & performance

D1W1MN

P/E

—

P/S

37.16

EPS

—

Div yield, %

—

Shrs. gr., 5y

60.28%

Rev. gr., 5y

27.67%

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product is the CADScor System, an exceptionally sensitive, non-invasive analytical device designed for the detection of coronary artery disease. Founded in 2009, Acarix AB (publ) maintains its headquarters in Malmö, Sweden.

URL

https://acarix.com/

IPO date

Dec 19, 2016

Employees

Domiciled in

Incorporated in

Valuation

No data to show